The coronavirus pandemic, which has taken our lives captive since 2019, has also mobilized the scientific world. Since the first days of the epidemic, experts have done their best to prevent this disease. In this regard, various protection and treatment methods, especially vaccines, have been developed. However, experts working at VA Boston Healthcare made an unprecedented discovery.
Scientists have researched the genes of some individuals who have had the disease since 2020. According to them, the gene may be the reason why the disease affects some less and some more. Recent studies have revealed that a gene sequence in humans can prevent severe transmission of COVID-19. Although there is still a lot of unknown, the studies to be done seem to be able to end the pandemic.
The effect of the gene on the disease is 23 percent.
Experts who examined the cases in Europe in 2020 found that a sequence in the OAS1/2/3 gene cluster was effective against antiviral diseases. Experts associating this gene sequence with COVID-19 revealed that the gene sequence prevented the severe recovery of the disease by 23 percent. The scientists, who deepened the study and examined African people as well as European people, succeeded in detecting the gene sequence in question. The gene named “rs10774671” significantly prevented hospitalizations due to coronavirus. The gene had a variant named “rs10774671 G” in European people and it functions the same.
Scientists state that the detected genes and variants are a legacy from the Neanderthal period and even much earlier. So what will actually protect us from the coronavirus is actually inside us. However, a lot of work still needs to be done and to understand whether the gene sequence is found in different populations. While experts are now working on it, a new treatment method that can trigger the gene could enable people to bypass COVID-19 like a common cold and not need precautions. . .